Page last updated: 2024-12-06
metabutoxycaine
Description
Metabutoxycaine is a local anesthetic that is structurally related to benzocaine. It is a white crystalline powder that is soluble in water and ethanol. Metabutoxycaine is used to relieve pain and itching associated with minor skin irritations, such as sunburn, insect bites, and poison ivy. It works by blocking the nerve impulses that transmit pain signals to the brain. Metabutoxycaine is available over-the-counter in various topical preparations, including creams, ointments, and sprays. Research on metabutoxycaine has focused on its potential applications in dentistry, ophthalmology, and dermatology. Studies have explored its efficacy and safety in treating pain and inflammation associated with dental procedures, eye surgery, and skin conditions. The compound is also being investigated for its potential use in pain management after surgery. Metabutoxycaine is generally well-tolerated, but some individuals may experience side effects such as skin irritation, redness, or itching. In rare cases, allergic reactions may occur. Metabutoxycaine is not recommended for use on open wounds or mucous membranes. It is important to consult with a healthcare professional before using metabutoxycaine, especially if you have any pre-existing medical conditions.'
metabutoxycaine: local anesthetic in operative dentistry [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 19247 |
CHEMBL ID | 2110975 |
CHEBI ID | 135313 |
SCHEMBL ID | 25778 |
MeSH ID | M0465670 |
Synonyms (20)
Synonym |
metabutoxycaine |
2'-diethylaminoethyl 3-amino-2-butoxybenzoate |
benzoic acid, 3-amino-2-butoxy-, 2-(diethylamino)ethyl ester |
2-butoxy-3-aminobenzoic acid beta-diethylaminoethyl ester |
beta-diethylaminoethyl 2-butoxy-3-aminobenzoate |
3-amino-2-butoxybenzoic acid 2-diethylaminoethyl ester |
CHEBI:135313 |
3624-87-1 |
unii-amv9l2wt8k |
amv9l2wt8k , |
metabutoxycaine [mi] |
2-(diethylamino)ethyl 3-amino-2-butoxybenzoate |
SCHEMBL25778 |
CHEMBL2110975 |
LJQWYEFHNLTPBZ-UHFFFAOYSA-N |
DTXSID40189787 |
Q6822370 |
ethanol, 2-diethylamino-, 3-amino-2-butoxybenzoate |
CS-0026326 |
HY-105613 |
Drug Classes (1)
Class | Description |
benzoate ester | Esters of benzoic acid or substituted benzoic acids. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 4 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |